For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
Op-Eds
The Church of Rachel Carson
One hundred years after her birth in May of 1907, it’s difficult to underestimate Rachel Carson’s influence. Unfortunately, it’s all bad. That hasn’t stopped…
Newsletter
CEI Daily Update
Issues in the News 1. Environment The Washington Post reports on the positive impact of global warming on residents…
Blog
USA Today: Full Medical Coverage or Nothing at All?
A write-up in USA Today by reporter Julie Appleby about health insurance gets some attention from our friends at the Business…
Blog
Chronic Vague Symptom Syndrome: Wi-Fi Edition
There’s more wi-fi scaremongering this week in The Indepedent, which cites an alleged wave of parents and school administrators in the UK who have…
Newsletter
The Competitive Enterprise Institute Daily Update
Monday, June 4, 2007 Issues in the News 1. SAFETY New laws governing the safety of…
Blog
Tensions within the FDA — Type I, Type II debate
An internecine struggle apparently exists within the FDA, according to an article in the New York Times. Those tensions between drug approval officials and…